IBDEI1N0 ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,29440,2)
 ;;=^338258
 ;;^UTILITY(U,$J,358.3,29441,0)
 ;;=453.89^^186^1872^8
 ;;^UTILITY(U,$J,358.3,29441,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,29441,1,4,0)
 ;;=4^AC Embolism Veins NEC
 ;;^UTILITY(U,$J,358.3,29441,1,5,0)
 ;;=5^453.89
 ;;^UTILITY(U,$J,358.3,29441,2)
 ;;=^338259
 ;;^UTILITY(U,$J,358.3,29442,0)
 ;;=447.1^^186^1872^77
 ;;^UTILITY(U,$J,358.3,29442,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,29442,1,4,0)
 ;;=4^Stricture of Artery
 ;;^UTILITY(U,$J,358.3,29442,1,5,0)
 ;;=5^447.1
 ;;^UTILITY(U,$J,358.3,29442,2)
 ;;=^114763
 ;;^UTILITY(U,$J,358.3,29443,0)
 ;;=355.71^^186^1872^26
 ;;^UTILITY(U,$J,358.3,29443,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,29443,1,4,0)
 ;;=4^Causalgia of Lower Limb
 ;;^UTILITY(U,$J,358.3,29443,1,5,0)
 ;;=5^355.71
 ;;^UTILITY(U,$J,358.3,29443,2)
 ;;=^295729
 ;;^UTILITY(U,$J,358.3,29444,0)
 ;;=444.89^^186^1872^14
 ;;^UTILITY(U,$J,358.3,29444,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,29444,1,4,0)
 ;;=4^Arterial Embolism NEC
 ;;^UTILITY(U,$J,358.3,29444,1,5,0)
 ;;=5^444.89
 ;;^UTILITY(U,$J,358.3,29444,2)
 ;;=^269793
 ;;^UTILITY(U,$J,358.3,29445,0)
 ;;=447.6^^186^1872^15
 ;;^UTILITY(U,$J,358.3,29445,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,29445,1,4,0)
 ;;=4^Arteritis NOS
 ;;^UTILITY(U,$J,358.3,29445,1,5,0)
 ;;=5^447.6
 ;;^UTILITY(U,$J,358.3,29445,2)
 ;;=^10396
 ;;^UTILITY(U,$J,358.3,29446,0)
 ;;=445.81^^186^1872^19
 ;;^UTILITY(U,$J,358.3,29446,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,29446,1,4,0)
 ;;=4^Atheroembolism,Kidney
 ;;^UTILITY(U,$J,358.3,29446,1,5,0)
 ;;=5^445.81
 ;;^UTILITY(U,$J,358.3,29446,2)
 ;;=^328516
 ;;^UTILITY(U,$J,358.3,29447,0)
 ;;=445.89^^186^1872^20
 ;;^UTILITY(U,$J,358.3,29447,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,29447,1,4,0)
 ;;=4^Atheroembolism,Other Site
 ;;^UTILITY(U,$J,358.3,29447,1,5,0)
 ;;=5^445.89
 ;;^UTILITY(U,$J,358.3,29447,2)
 ;;=^328517
 ;;^UTILITY(U,$J,358.3,29448,0)
 ;;=904.9^^186^1872^23
 ;;^UTILITY(U,$J,358.3,29448,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,29448,1,4,0)
 ;;=4^Blood Vessel Injury NOS
 ;;^UTILITY(U,$J,358.3,29448,1,5,0)
 ;;=5^904.9
 ;;^UTILITY(U,$J,358.3,29448,2)
 ;;=^275212
 ;;^UTILITY(U,$J,358.3,29449,0)
 ;;=682.9^^186^1872^27
 ;;^UTILITY(U,$J,358.3,29449,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,29449,1,4,0)
 ;;=4^Cellulitis NOS
 ;;^UTILITY(U,$J,358.3,29449,1,5,0)
 ;;=5^682.9
 ;;^UTILITY(U,$J,358.3,29449,2)
 ;;=^21160
 ;;^UTILITY(U,$J,358.3,29450,0)
 ;;=682.0^^186^1872^31
 ;;^UTILITY(U,$J,358.3,29450,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,29450,1,4,0)
 ;;=4^Cellulitis of Face
 ;;^UTILITY(U,$J,358.3,29450,1,5,0)
 ;;=5^682.0
 ;;^UTILITY(U,$J,358.3,29450,2)
 ;;=^271888
 ;;^UTILITY(U,$J,358.3,29451,0)
 ;;=682.1^^186^1872^32
 ;;^UTILITY(U,$J,358.3,29451,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,29451,1,4,0)
 ;;=4^Cellulitis of Neck
 ;;^UTILITY(U,$J,358.3,29451,1,5,0)
 ;;=5^682.1
 ;;^UTILITY(U,$J,358.3,29451,2)
 ;;=^271889
 ;;^UTILITY(U,$J,358.3,29452,0)
 ;;=682.2^^186^1872^33
 ;;^UTILITY(U,$J,358.3,29452,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,29452,1,4,0)
 ;;=4^Cellulitis of Trunk
 ;;^UTILITY(U,$J,358.3,29452,1,5,0)
 ;;=5^682.2
 ;;^UTILITY(U,$J,358.3,29452,2)
 ;;=^271890
 ;;^UTILITY(U,$J,358.3,29453,0)
 ;;=414.8^^186^1872^34
 ;;^UTILITY(U,$J,358.3,29453,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,29453,1,4,0)
 ;;=4^Chr Ischemic Hrt Disease NEC
 ;;^UTILITY(U,$J,358.3,29453,1,5,0)
 ;;=5^414.8
 ;;^UTILITY(U,$J,358.3,29453,2)
 ;;=^269680
 ;;^UTILITY(U,$J,358.3,29454,0)
 ;;=707.10^^186^1872^91
 ;;^UTILITY(U,$J,358.3,29454,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,29454,1,4,0)
 ;;=4^Ulcer of Lower Limb,Unspec
